Public Sector Pension Investment Board (PSP Investments)’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,038
Closed -$232K 1401
2023
Q1
$232K Sell
22,038
-926
-4% -$28K ﹤0.01% 1390
2022
Q4
$778K Hold
22,964
0.01% 1290
2022
Q3
$1.1M Hold
22,964
0.01% 1125
2022
Q2
$1.31M Hold
22,964
0.01% 1055
2022
Q1
$1.86M Sell
22,964
-2,096
-8% -$310K 0.01% 1043
2021
Q4
$5.08M Buy
+25,060
New +$5.44M 0.03% 565
2019
Q4
Sell
-2,247
Closed -$614K 1560
2019
Q3
$614K Buy
2,247
+727
+48% +$267K ﹤0.01% 1365
2019
Q2
$811K Buy
1,520
+553
+57% +$277K 0.01% 1318
2019
Q1
$487K Buy
967
+374
+63% +$222K ﹤0.01% 1344
2018
Q4
$293K Sell
593
-1,434
-71% -$866K ﹤0.01% 1484
2018
Q3
$1.85M Buy
2,027
+1,427
+238% +$1.22M 0.01% 667
2018
Q2
$439K Hold
600
﹤0.01% 1224
2018
Q1
$956K Sell
600
-6,017
-91% -$7.75M 0.01% 792
2017
Q4
$5.93M Buy
6,617
+107
+2% +$63.3K 0.04% 325
2017
Q3
$2.34M Buy
6,510
+1,217
+23% +$381K 0.01% 450
2017
Q2
$1.55M Sell
5,293
-2,087
-28% -$603K 0.01% 545
2017
Q1
$2.6M Buy
7,380
+133
+2% +$29.9K 0.02% 533
2016
Q4
$1.33M Buy
7,247
+814
+13% +$166K 0.01% 752
2016
Q3
$1.66M Hold
6,433
0.02% 635
2016
Q2
$1.37M Buy
6,433
+166
+3% +$37.1K 0.02% 653
2016
Q1
$1.29M Hold
6,267
0.01% 627
2015
Q4
$1.58M Sell
6,267
-3,446
-35% -$709K 0.01% 633
2015
Q3
$1.6M Sell
9,713
-3,620
-27% -$640K 0.01% 728
2015
Q2
$2.5M Buy
+13,333
New +$2.29M 0.02% 709

Other funds holding NKTR

Public Sector Pension Investment Board (PSP Investments)'s NKTR Position: Q2 2023 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 22,038 shares — an estimated $232K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in NKTR in Q2 2015 and held it in 24 quarters. The position peaked at $5.93M in Q4 2017. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 22,038 Nektar Therapeutics shares in Q2 2023, an estimated $232K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Nektar Therapeutics in Q2 2015 and held it in 24 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Nektar Therapeutics position peaked at $5.93M in Q4 2017.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2023, filed 14 Aug 2023.